• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FRESENIUS KABI DEUTSCHLAND GMBH VOLUMAT LINE; ADMINISTRATION SET, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FRESENIUS KABI DEUTSCHLAND GMBH VOLUMAT LINE; ADMINISTRATION SET, INTRAVASCULAR Back to Search Results
Model Number VL PR44-12
Medical Device Problem Code No Apparent Adverse Event (3189)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/18/2025
Type of Reportable Event Malfunction
Event or Problem Description
The following has been reported: primary line infusing chemotherapy leaked at the distal port (port farthest from the pump).The glue appeared to look stringy and let go from the plastic end of the port.A small amount of chemotherapy leaked onto the patient's arm, chair, and floor.No adverse event was communicated.Investigation summary as follows: 1.Reported complaint leakage at needle free port 2.Quantity of the sample(s) no complaint sample available for investigation, only one photo 3.Concerned product code/batch infusion set vl pr44-12 (nam) - m46445780 / batch unknown 4.Investigation report we have not received a complaint sample for investigation.We received one photo witch shows part of our product inside the foil bag - only k-zero and tube.It was visible a drops of fluid inside the bag.Nevertheless, it is not clearly visible a place of leakage.Based on photo we did not able to confirm where the leakage occured.As we did not receive the batch number, an inspection of retained samples and review of batch documentation was not possible.Without faulty sample and batch number, a more detailed investigation was not possible.In the last 12 months (from (b)(6) 2024 to (b)(6) 2025) we have received 1 complaint for this article with the same reason as "leakage at needle free port".5.Root cause without the complaint sample and batch number root cause analysis we are not able to perform adequate root cause analyses.6.Corrective action.Corrective and preventive actions are not necessary as we are not able to perform root cause analyses 7.Conclusion based on these results we are not able to confirm this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLUMAT LINE
Common Device Name
ADMINISTRATION SET, INTRAVASCULAR
Manufacturer (Section D)
FRESENIUS KABI DEUTSCHLAND GMBH
5 robert-koch-strasse
bad hersfeld, hessen 36521
GM  36521
MDR Report Key23751493
Report Number3004548776-2025-00622
Device Sequence Number21189239
Product Code FPA
UDI-Device Identifier04250273731965
UDI-Public04250273731965
Combination Product (Y/N)N
Initial Reporter CountryCA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Importer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 12/08/2025
Report Date (Section F) 12/08/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberVL PR44-12
Device Catalogue NumberM46445780
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date11/27/2025
Event Location Hospital
Date Report to Manufacturer12/08/2025
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date12/08/2025
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
Date Report Sent to FDA12/08/2025
-
-